You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Early-Stage NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Early-stage Lung Cancer Trial in Nijmegen (99mTc-nanocolloid, ICG)

Recruiting
  • Early-stage Lung Cancer
  • 99mTc-nanocolloid
  • ICG
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Dec 9, 2022

NSCLC Trial in Kansas City (Non-ablative SBRT)

Recruiting
  • Non-small Cell Lung Cancer
  • Non-ablative SBRT
  • Kansas City, Kansas
    University of Kansas Medical Center
Mar 21, 2022

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Stanford, California
    Stanford University
Mar 25, 2022

NSCLC Trial in Philadelphia (device, drug, other)

Not yet recruiting
  • NSCLC
  • Aliya Pulsed Electric Fields (PEF) ablation
  • +3 more
  • Philadelphia, Pennsylvania
    Temple University
Oct 24, 2022

Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV

Recruiting
  • Stage II-III Non-small Cell Lung Cancer
  • 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
  • 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
  • Shanghai, China
    Shanghai Chest Hospital
Apr 12, 2022

Lung Cancer Stage I, Lung Cancer Stage II, Lung Metastases Trial in Amsterdam, Leiden (Cardiac condition measurements)

Recruiting
  • Lung Cancer Stage I
  • +2 more
  • Cardiac condition measurements
  • Amsterdam, Netherlands
  • +2 more
Jul 9, 2021

Lung Cancer, Surgery, Circulating Tumor Cell Trial in Amsterdam, Leiden (Cetuximab)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Amsterdam, Netherlands
  • +1 more
Oct 19, 2021

NSCLC Trial in Beijing

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Beijing, China
      Peking University People's Hospital
    Apr 23, 2022

    NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)

    Recruiting
    • Non-small Cell Lung Cancer
    • Porto, Portugal
      Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
    Feb 23, 2022

    NSCLC, NSCLC, Lung Cancer Trial in United States (Durvalumab, Stereotactic Body Radiation Therapy)

    Recruiting
    • NSCLC
    • +7 more
    • Hartford, Connecticut
    • +8 more
    Jul 7, 2022

    Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early

    Withdrawn
    • NSCLC
    • Non Small Cell Lung Cancer
    • Cesium-131 Brachytherapy Seed
    • New York, New York
      Weill Cornell Medical College
    Mar 25, 2021

    NSCLC Trial in Burlington (cis-diamminedichloroplatinum)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Burlington, Vermont
      University of Vermont
    May 20, 2022

    Lung Cancer Trial in Amsterdam (stereotactic radiotherapy, primary surgery)

    Terminated
    • Lung Cancer
    • stereotactic radiotherapy
    • primary surgery
    • Amsterdam, Netherlands
      VU University Medical Center
    Mar 16, 2022

    Early Stage NSCLC Trial in Tianjin (Biological: Camrelizumab, Pemetrexed, Nab-paclitaxel)

    Recruiting
    • Early Stage Non-small Cell Lung Cancer
    • Biological: Camrelizumab
    • +2 more
    • Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Nov 10, 2020

    Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC

    Terminated
    • Non Small Cell Lung Cancer
    • biospecimen collection
    • Atlanta, Georgia
    • +5 more
    Nov 18, 2020

    Non Small Cell Lung Cancer Trial in Boston (DCE-MRI scan, Stereotactic Body Radiation Therapy, 4D-CT scan)

    Terminated
    Has Results
    • Non Small Cell Lung Cancer
    • DCE-MRI scan
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Sep 15, 2021

    Early Stage NSCLC Trial in La Jolla, Sioux Falls (Avelumab, SBRT)

    Terminated
    • Early Stage Non-Small Cell Lung Cancer
    • La Jolla, California
    • +1 more
    Apr 29, 2021

    Resectable, Early-stage, NSCLC Trial in Worldwide (Durvalumab, Oleclumab, Monalizumab)

    Completed
    Has Results
    • Resectable
    • +2 more
    • La Jolla, California
    • +17 more
    Feb 23, 2022

    Tumor Tissue Samples From Early-Stage Non-Small Cell Lung Cancer

    Completed
    • Lung Cancer
    • laboratory biomarker analysis
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Aug 16, 2021

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Lung Cancer Stage III Trial (ctDNA)

    Not yet recruiting
    • Lung Cancer Stage III
    • ctDNA
    • (no location specified)
    Oct 26, 2023

    Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

    Recruiting
    • Non-small Cell Lung Cancer
      • Seoul, Korea, Republic of
        Samsung Medical Center
      May 9, 2021

      High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

      Suspended
      • NSCLC Stage IV
      • NSCLC, Stage IIIC
      • Primary Immune Response (PIR) test by Biodesix, Inc.
      • San Carlos, California
      • +1 more
      Jan 26, 2023

      NSCLC Trial in Gainesville, Jacksonville (Daily Stereotactic Body Radiotherapy, Non-Daily Stereotactic Body Radiotherapy)

      Terminated
      • Non-small Cell Lung Cancer
      • Daily Stereotactic Body Radiotherapy
      • Non-Daily Stereotactic Body Radiotherapy
      • Gainesville, Florida
      • +1 more
      Sep 27, 2021